Gamma Knife Radiosurgery for Metastatic Melanoma: An Analysis of Survival, Outcome, and Complications

医学 放射外科 放射治疗 脑转移 黑色素瘤 外科 人口 转移 放射科 内科学 癌症 癌症研究 环境卫生
作者
Sean D. Lavine,Zbigniew Petrovich,Aaron Cohen‐Gadol,Lena S. Masri,Donald L. Morton,Steven O’Day,Richard Essner,Vladimir Zelman,Cheng Yu,Gary Luxton,Michael L.J. Apuzzo
出处
期刊:Neurosurgery [Lippincott Williams & Wilkins]
卷期号:44 (1): 59-64 被引量:118
标识
DOI:10.1097/00006123-199901000-00031
摘要

OBJECTIVE: Although the mainstays for treatment of metastatic brain disease have been surgery and/or external beam radiation therapy, an increasing number of patients are being referred for stereotactic radiosurgery as the primary intervention for their intracranial pathological abnormalities. The lack of efficacy and cognitive and behavioral consequences of whole brain irradiation have prompted clinicians to select patients for alternative therapies. This study analyzes the effectiveness of Leksell gamma unit therapy for metastatic melanoma to the brain. METHODS: We present our experience with 59 Leksell gamma unit treatment sessions in 45 consecutive patients who presented with metastatic melanoma to the brain. Five of these procedures were performed as salvage therapy for patients who needed second radiosurgical treatment for new lesions that were remote from the previous targets and were not included in the overall analyses. RESULTS: The population included 78% male patients. The mean patient age was 53 years (age range, 24-80 yr). The mean time from diagnosis of primary melanoma to discovery of brain metastasis was 43 months (median, 27.5 mo; range, 1-180 mo). At the time of diagnosis of brain disease, 35.5% of the patients (16 of 45 patients) had neurological symptoms, 77.7% (35 of 45 patients) had known visceral metastases, and 11.1% (5 of 45 patients) had seizure disorders. Eighty-six percent of the lesions (80 of 93 lesions) were cortical, 12% (11 of 93 lesions) were cerebellar, 1% (1 of 93 lesions) were pontine, and 1% (1 of 93 lesions) were thalamic. Fifty-seven percent of the sessions (31 of 54 sessions) were performed for a single lesion, 24.1% (13 of 54 sessions) for two lesions, 9.2% (5 of 54 sessions) for three lesions, 7.4% (4 of 54 sessions) for four lesions, and 1.8% (1 of 54 sessions) for five lesions. The mean treatment volume was 5.6 cc, with a mean prescription of 21.6 Gy to the 56.0% mean isodose line. The median survival time of the patients in our population, using Kaplan-Meier curves, was 43 months from the time of diagnosis of primary melanoma (range, 3-180 mo) and 8 months (range, 1-20 mo) from the time of gamma knife treatment. Complications included seizures within 24 hours of the procedure in four patients, with transient nausea and vomiting in three patients, transient worsening of preprocedure paresis responsive to steroids in three patients, and increased confusion in one patient. All 45 patients were located for follow-up (mean follow-up duration, 1 yr). After gamma knife treatment, 78% of the patients (35 of 45 patients) experienced either improved or stable neurological symptomatology before death or at the time of the latest follow-up examination. There were 26 deaths (58%). The cause of death was determined to be neurological in only 2 of 45 patients (7.7%). Follow-up magnetic resonance images revealed a 97% local tumor control rate of gamma knife-treated lesions, with 28% radiographic disappearance (9 of 32 cases). Six patients developed new lesions remote from radiosurgical targets and underwent second procedures. CONCLUSION: Although metastatic melanoma to the brain continues to have a foreboding prognosis for long-term survival, gamma knife radiosurgery seems to be a relatively safe, noninvasive, palliative therapy, halting or reversing neurological progression in 77.8% of treated patients (35 of 45 patients). The survival rate matches or exceeds those previously reported for surgery and other forms of radiotherapy. Only 7.7% of the patients in our study population who died as a result of metastatic melanoma (2 of 26 patients) died as a result of neurological disease. The routine use of therapeutic level antiseizure medication is emphasized, considering the findings of our review.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
lc完成签到,获得积分10
刚刚
酷波er的应助被孤独超短裙采纳,获得10
1秒前
1秒前
1秒前
完美世界的应助被GangBer采纳,获得10
1秒前
绵绵冰发布了新的文献求助10
2秒前
好孩子完成签到,获得积分10
2秒前
学术小张完成签到,获得积分10
2秒前
tkyy完成签到,获得积分10
2秒前
文承龙发布了新的文献求助10
2秒前
火星上的帅哥完成签到,获得积分20
3秒前
王井彦发布了新的文献求助10
3秒前
臭小子发布了新的文献求助10
3秒前
务实问凝完成签到,获得积分20
4秒前
完美世界的应助被甜美紫真采纳,获得10
4秒前
111完成签到,获得积分10
4秒前
风吹麦浪的应助被Loooong采纳,获得10
4秒前
yan发布了新的文献求助10
4秒前
顾矜的应助被跑不掉的可乐猪采纳,获得10
4秒前
sfhklqwe发布了新的文献求助10
5秒前
jzmulyl发布了新的文献求助10
5秒前
5秒前
79999发布了新的文献求助10
5秒前
5秒前
彭于彦祖的应助被疯狂鱼博士采纳,获得30
6秒前
beginner发布了新的文献求助10
6秒前
Aspire发布了新的文献求助10
6秒前
角度更多完成签到,获得积分10
7秒前
gengssss完成签到,获得积分10
7秒前
8秒前
8秒前
8秒前
柯不惜发布了新的文献求助10
8秒前
你你你完成签到,获得积分10
9秒前
9秒前
9秒前
ZnCu完成签到 ,获得积分10
10秒前
LuoYR@SZU完成签到,获得积分10
10秒前
123发布了新的文献求助30
10秒前
脑洞疼的应助被624794951采纳,获得10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8162621
求助须知:如何正确求助?哪些是违规求助? 9556889
关于积分的说明 21737583
捐赠科研通 7753002
什么是DOI,文献DOI怎么找? 3427836
关于科研通互助平台的介绍 2552719
邀请新用户注册赠送积分活动 2472507